Literature DB >> 23873136

Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis.

Marco Peviani1, Massimo Tortarolo, Elisa Battaglia, Roberto Piva, Caterina Bendotti.   

Abstract

Evidence is accumulating that an imbalance between pathways for degeneration or survival in motor neurons may play a central role in mechanisms that lead to neurodegeneration in amyotrophic lateral sclerosis (ALS). We and other groups have observed that downregulation, or lack of induction, of the PI3K/Akt prosurvival pathway may be responsible for defective response of motor neurons to injury and their consequent cellular demise. Some of the neuroprotective effects mediated by growth factors may involve activation of Akt, but a proof of concept of Akt as a target for therapy is lacking. We demonstrate that specific expression of constitutively activated Akt3 in motor neurons through the use of the promoter of homeobox gene Hb9 prevents neuronal loss induced by SOD1.G93A both in vitro (in mixed neuron/astrocyte cocultures) and in vivo (in a mouse model of ALS). Inhibition of ASK1 and GSK3beta was involved in the neuroprotective effects of activated Akt3, further supporting the hypothesis that induction of Akt3 may be a key step in activation of pathways for survival in the attempt to counteract motor neuronal degeneration in ALS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873136     DOI: 10.1007/s12035-013-8507-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  67 in total

1.  Crosstalk between p38, Hsp25 and Akt in spinal motor neurons after sciatic nerve injury.

Authors:  A K Murashov; I U Haq; C Hill; E Park; M Smith; X Wang; X Wang; D J Goldberg; D J Wolgemuth
Journal:  Brain Res Mol Brain Res       Date:  2001-09-30

2.  Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2.

Authors:  M Azzouz; A Hottinger; J C Paterna; A D Zurn; P Aebischer; H Büeler
Journal:  Hum Mol Genet       Date:  2000-03-22       Impact factor: 6.150

Review 3.  Rodent models of TDP-43: recent advances.

Authors:  William Tsao; Yun Ha Jeong; Sophie Lin; Jonathan Ling; Donald L Price; Po-Min Chiang; Philip C Wong
Journal:  Brain Res       Date:  2012-05-01       Impact factor: 3.252

4.  Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis.

Authors:  Makoto Urushitani; Junko Kurisu; Kayoko Tsukita; Ryosuke Takahashi
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

5.  Early decrease of survival signal-related proteins in spinal motor neurons of presymptomatic transgenic mice with a mutant SOD1 gene.

Authors:  H Warita; Y Manabe; T Murakami; Y Shiro; I Nagano; K Abe
Journal:  Apoptosis       Date:  2001-10       Impact factor: 4.677

6.  Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.

Authors:  Erik Storkebaum; Diether Lambrechts; Mieke Dewerchin; Maria-Paz Moreno-Murciano; Saskia Appelmans; Hideyasu Oh; Philip Van Damme; Bart Rutten; Wing Yan Man; Maria De Mol; Sabine Wyns; David Manka; Kristel Vermeulen; Ludo Van Den Bosch; Nico Mertens; Christoph Schmitz; Wim Robberecht; Edward M Conway; Désiré Collen; Lieve Moons; Peter Carmeliet
Journal:  Nat Neurosci       Date:  2004-11-28       Impact factor: 24.884

7.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

8.  Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.

Authors:  Li-Jun Wang; Yan-Yan Lu; Shin-ichi Muramatsu; Kunihiko Ikeguchi; Ken-ichi Fujimoto; Takashi Okada; Hiroaki Mizukami; Takashi Matsushita; Yutaka Hanazono; Akihiro Kume; Toshiharu Nagatsu; Keiya Ozawa; Imaharu Nakano
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

9.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

10.  Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.

Authors:  M Tortarolo; P Veglianese; N Calvaresi; A Botturi; C Rossi; A Giorgini; A Migheli; C Bendotti
Journal:  Mol Cell Neurosci       Date:  2003-06       Impact factor: 4.314

View more
  18 in total

1.  CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.

Authors:  Maria Chiara Trolese; Alessandro Mariani; Mineko Terao; Massimiliano de Paola; Paola Fabbrizio; Francesca Sironi; Mami Kurosaki; Silvia Bonanno; Silvia Marcuzzo; Pia Bernasconi; Francesca Trojsi; Eleonora Aronica; Caterina Bendotti; Giovanni Nardo
Journal:  EBioMedicine       Date:  2020-11-09       Impact factor: 8.143

2.  Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model.

Authors:  Gabriela P de Oliveira; Jessica R Maximino; Mariana Maschietto; Edmar Zanoteli; Renato D Puga; Leandro Lima; Dirce M Carraro; Gerson Chadi
Journal:  Cell Mol Neurobiol       Date:  2014-01-18       Impact factor: 5.046

3.  Cytotoxic Effects of Environmental Toxins on Human Glial Cells.

Authors:  Fiona D'Mello; Nady Braidy; Helder Marçal; Gilles Guillemin; Fanny Rossi; Mirielle Chinian; Dominique Laurent; Charles Teo; Brett A Neilan
Journal:  Neurotox Res       Date:  2016-10-29       Impact factor: 3.911

4.  Endothelin-1 Induces Degeneration of Cultured Motor Neurons Through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway.

Authors:  S D'Antoni; E Ranno; M Spatuzza; S Cavallaro; M V Catania
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

5.  Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Casey J Lumpkin; Ashlee W Harris; Luciano Saieva; Jonathan D Edwards; Eileen Workman; Louise R Simard; Livio Pellizzoni; Arthur H M Burghes
Journal:  Exp Neurol       Date:  2016-02-15       Impact factor: 5.330

6.  Critical roles of ARHGAP36 as a signal transduction mediator of Shh pathway in lateral motor columnar specification.

Authors:  Heejin Nam; Shin Jeon; Hyejin An; Jaeyoung Yoo; Hyo-Jong Lee; Soo-Kyung Lee; Seunghee Lee
Journal:  Elife       Date:  2019-07-15       Impact factor: 8.140

7.  An ALS-Associated Mutant SOD1 Rapidly Suppresses KCNT1 (Slack) Na+-Activated K+ Channels in Aplysia Neurons.

Authors:  Yalan Zhang; Weiming Ni; Arthur L Horwich; Leonard K Kaczmarek
Journal:  J Neurosci       Date:  2017-01-24       Impact factor: 6.167

8.  The change tendency of PI3K/Akt pathway after spinal cord injury.

Authors:  Peixun Zhang; Luping Zhang; Lei Zhu; Fangmin Chen; Shuai Zhou; Ting Tian; Yuqiang Zhang; Xiaorui Jiang; Xuekun Li; Chuansen Zhang; Lin Xu; Fei Huang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

9.  Altered Metabolic Profiles Associate with Toxicity in SOD1G93A Astrocyte-Neuron Co-Cultures.

Authors:  Gabriel N Valbuena; Massimo Tortarolo; Caterina Bendotti; Lavinia Cantoni; Hector C Keun
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

Review 10.  Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.

Authors:  Fiona Haxho; Ronald J Neufeld; Myron R Szewczuk
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.